Liverpool Science Park News & Press
Two North West companies have received investments from the £25m North West Fund for Biomedical.
Aventé Medical Products Ltd, which is in the process relocating to
Liverpool, and Daresbury-based TopCat Research, have each secured
£50,000 Pathfinder Investments from the Fund.
The £25m North West Fund for Biomedical is run by early-stage venture capital firm SPARK Impact and is part of the £185m evergreen fund provided by the European Investment Bank (EIB) and European Regional Development Fund (ERDF), to supply debt and equity funding to small and medium sized enterprises in the North West of England.
Aventé Medical Products Ltd, established in May 2011, has
ambitious plans to develop a range of high-quality, cost-effective,
single-use medical
devices for which they have already received positive encouragement
from both the NHS and private healthcare purchasers. The £50K
Pathfinder Investment will be used to consolidate the company's
intellectual property position, complete an independent market
survey and finalise product design in preparation for
manufacture.
TopCat Research, based in Daresbury, Cheshire, is developing costeffective immunoassay-based diagnostic tests for the pharmaceutical environmental and food markets. The £50K Pathfinder Investment will be used to take its first diagnostic kit from R&D to prototype stage.
- Business set to benefit from new intensive coaching programme
- A good idea can go a long way. How far will yours go?
- Key Travel snaps up academic specialist
- £7.6M funding package secured for third building at Liverpool Science Park
- The Technology Strategy Board speaks at Liverpool Science Park
- LIVERPOOL SCIENCE PARK LATEST RESIDENT ARE TOP 10 IN THE CITY
- Active Profile takes on trio of new technologies
- THE North West Fund for Biomedical has made an investment in the world’s first intelligent urology leg bag
- Merseyside pharmaceutical firm secures Series A investment package
- Mando Group Launch Amplifon Site Revamp
